Palvella expands QTORIN rapamycin development to angiokeratomas

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. PANW
2. GTLB
3. MDB
4. DELL
5. GOOGL
6. VRTS
7. SPY
8. HPE
9. USO
10. SNOW

Go back to Palvella expands QTORIN rapamycin development to angiokeratomas
(NASDAQ: PVLA) Delayed: 152.95 +2.40 (1.59%)
Previous Close $150.55    52 Week High $ 
Open $153.76    52 Week Low $ 
Day High $157.00    P/E N/A 
Day Low $149.68    EPS $ 
Volume 125,223